Expert Pitch
Washington University in St. Louis

Mathematical Model Predicts COVID-19 Hospitalizations for Those with Underlying Conditions

27-Apr-2020 6:05 AM EDT, by Washington University in St. Louis

Washington University in St. Louis mathematician Steven G. Krantz has turned his focus to modeling COVID-19 in hopes that better predictions can help lessen transmission and save lives.

Krantz is working with Arni S.R. Srinivasa Rao, director of the Laboratory for Theory and Mathematical Modeling in the Division of Infectious Diseases at the Medical College of Georgia at Augusta University.

Their latest study — now available on the medical preprint server medRxiv — predicts the number of hospitalizations that could occur for people over age 65 with one or a combination of three underlying conditions: hypertension, cardiovascular disease and lung disease.

Researchers estimate that there are 13 million such individuals in the United States who need to be protected against COVID-19 to reduce a large number of hospitalizations and associated deaths.

The novel models rely on a mathematical tool called wavelets. Working with Rao, Krantz has prepared in the past six weeks five publications for improving a variety of projections about the novel coronavirus.

“Wavelets provide, for the first time, a way to see the difference in magnitudes between the reported size and the adjusted size of an epidemic,” said Krantz, professor of mathematics and statistics in Arts & Sciences.

A wavelet is an oscillation which — as the name implies — goes up, peaks and then recedes like a wave. First used in signal processing more than 30 years ago, wavelets are useful in modeling epidemics because they can help bridge a gap in understanding by estimating the amount of underreporting. The higher the wave, the higher the underreporting — and a lower wave means improved reporting.

Immediate, near-term predictions about new COVID-19 infections

The newest model that Krantz and Rao have prepared provides immediate and near-term future predictions about the number of new COVID-19 infections among high-risk populations. Not every COVID-19 infection requires hospitalization, and better predictions about the potential volume of patients requiring inpatient care can assist in resource planning, the researchers noted.

Hospitalizations of patients aged 65 and older with more prevalent underlying conditions could range between 31,633 (20,310 non-ICU hospitalizations and 11,323 ICU admissions) to 94,666 (60,779 non-ICU hospitalizations and 33,866 ICU admissions) cases from April to June 2020, according to the new model, which has not yet been peer reviewed.

Krantz and Rao have hastened to share their related wavelets work in general scientific journals, including Infection Control & Hospital Epidemiology, Current Science and the Journal of Theoretical Biology. Rao is the corresponding author for the hospitalization study.

Using publicly available COVID-19 data from sources like the World Health Organization, they have modeled underreporting, including underdiagnosis, before the first peaks in various countries. They have also focused on what was happening in specific countries. For example, one of their findings, based on limited data, suggests that the U.S. may have had up to 90,000 COVID-19 cases in early March, even though official counts showed only 500 cases at the time.

“I can tell you that if I submitted a pure math paper to a pure math journal and tried to talk the editor into fast-tracking it, I would, in most instances, be laughed at,” Krantz said. “But obviously the COVID-19 epidemic is a vital and important topic, and the work that Rao and I are doing is timely and significant.

“Finding the true magnitude of a pandemic is important in framing policies,” Krantz said. “Considering only the reported magnitude is insufficient. The feedback we get from our readers is uniformly supportive and appreciative.”

Krantz first met Rao about six years ago when Krantz was serving as editor of the Notices of the American Mathematical Society. The two started collaborating about three years ago, and Rao visited Washington University in 2018.

“Rao is a prominent mathematical modeler whose works are well known,” Krantz said. “He has been working on mathematical and stochastic modeling of epidemics like HIV, HCV and bird flu for the past two decades.”

“One possible reason that underreporting has not been studied for previous epidemics is that the daily reporting and updates were not taken as seriously as for COVID-19,” Krantz said. This is the first outbreak to garner such intense international attention to reporting in real-time.

Krantz has previously applied mathematical models to pharmaceutical concerns and also collaborated with a plastic surgeon in designing plastic surgery procedures using geometry and wavelets.

“That was satisfying because, unlike my pure math work, I could actually talk to non-specialists about what I was doing,” Krantz said. “I can also talk to non-specialists about my COVID-19 work, and the work is socially significant.

“It means a lot to me that my mathematics can have a social impact and perhaps even save lives.”

WashU Response to COVID-19
Visit for the latest information about WashU updates and policies. See all stories related to COVID-19.

Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.

Showing results

110 of 2539